Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2016 1
2017 1
2018 1
2021 1
2022 2
2024 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma.
Tavakoli S, Samareh-Salavati M, Abdolahi S, Verdi J, Seyhoun I, Vousooghi N, Vaezi M, Ghaderi A, Ghavamzadeh A, Barkhordar M, Ahmadvand M. Tavakoli S, et al. Adv Pharm Bull. 2024 Dec 30;14(4):918-926. doi: 10.34172/apb.43869. Epub 2024 Dec 5. Adv Pharm Bull. 2024. PMID: 40190667 Free PMC article.
Anti-NKG2A pretreated NK cells were infused on days 0,+5, and+10 post-conditioning regimens at a dose of 7 10(8) cells (n=3). The median follow-up was 4 months for all patients. RESULTS: Although all patients were alive at the last follow-up, two of them showed progressive …
Anti-NKG2A pretreated NK cells were infused on days 0,+5, and+10 post-conditioning regimens at a dose of 7 10(8) cells (n=3). The med …
Dose-dependent effect of megestrol acetate supplementation in cancer patients with anorexia-cachexia syndrome: A meta-analysis.
Talebi S, Zeraattalab-Motlagh S, Barkhordar M, Vaezi M, Ghoreishy SM, Ghavami A, Hosseini Y, Travica N, Mohammadi H. Talebi S, et al. J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1254-1263. doi: 10.1002/jcsm.13500. Epub 2024 Jun 20. J Cachexia Sarcopenia Muscle. 2024. PMID: 39031821 Free PMC article. Review.

MA administration significantly affected the quality of life based on pooled effect sizes (MD: 1.15, 95% CI [0.76, 1.54], P < 0.001, I(2) = 0%; n = 2 RCTs including 176 patients; GRADE = very low certainty). However, no significant effect of MA supplementation was obser

…

MA administration significantly affected the quality of life based on pooled effect sizes (MD: 1.15, 95% CI [0.76, 1.54], P < 0.001, I(2)

…
Renal sarcomas in children and adolescents: a retrospective, multicenter cohort study.
McKay KG, Beckhorn C, Kontchou NT, Kastenberg ZJ, Roach J, Mullapudi B, Lautz TB, Dasgupta R, Talbot LJ, Aldrink JH, Piché N, Craig BT, Cromeens B, Castle SL, Short J, Petroze RT, Mattei P, Rothstein DH, Fialkowski EA, Rich BS, Brown EG, Seemann NM, Le HD, Ahmed TM, Newman EA, Grant CN, Polites SF, Cameron DB, Kim ES, Austin MT, Coakley BA, Murphy JT, Boehmer C, Malek MM, Tracy E, Lovvorn HN 3rd; Pediatric Surgical Oncology Research Collaborative. McKay KG, et al. EClinicalMedicine. 2025 Dec 18;91:103713. doi: 10.1016/j.eclinm.2025.103713. eCollection 2026 Jan. EClinicalMedicine. 2025. PMID: 41509607 Free PMC article.
FINDINGS: Among 158 patients, clear cell sarcoma of the kidney (CCSK; n = 94), Ewing sarcoma (EWS; n = 33), and undifferentiated sarcoma (n = 8) predominated. ...Hematogenous metastases occurred most in the lungs (n = 19 total; 10 with EWS), followed b …
FINDINGS: Among 158 patients, clear cell sarcoma of the kidney (CCSK; n = 94), Ewing sarcoma (EWS; n = 33), and undifferentiat …
Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience.
Barkhordar M, Kasaeian A, Janbabai G, Mousavi SA, Fumani HK, Tavakoli S, Bahri T, Ghavamzadeh A, Vaezi M. Barkhordar M, et al. Leuk Res. 2022 Sep;120:106918. doi: 10.1016/j.leukres.2022.106918. Epub 2022 Jul 12. Leuk Res. 2022. PMID: 35843087
We retrospectively compared the long-term outcomes of adult acute myeloid leukemia (AML) patients undergoing a haplo-HSCT (n = 92) with a new modified combination of ATG and PTCy in the context of peripheral blood stem cell (PBSC) and myeloablative conditioning (MAC) with …
We retrospectively compared the long-term outcomes of adult acute myeloid leukemia (AML) patients undergoing a haplo-HSCT (n = 92) wi …
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial.
Jädersten M, Lilienthal I, Tsesmetzis N, Lourda M, Bengtzén S, Bohlin A, Arnroth C, Erkers T, Seashore-Ludlow B, Giraud G, Barkhordar GS, Tao S, Fogelstrand L, Saft L, Östling P, Schinazi RF, Kim B, Schaller T, Juliusson G, Deneberg S, Lehmann S, Rassidakis GZ, Höglund M, Henter JI, Herold N. Jädersten M, et al. J Intern Med. 2022 Dec;292(6):925-940. doi: 10.1111/joim.13553. Epub 2022 Aug 18. J Intern Med. 2022. PMID: 35934913 Free PMC article. Clinical Trial.
Maghemite nanoparticle-decorated hollow fiber electromembrane extraction combined with dispersive liquid-liquid microextraction for determination of thymol from Carum copticum.
Khajeh M, Pedersen-Bjergaard S, Bohlooli M, Barkhordar A, Ghaffari-Moghaddam M. Khajeh M, et al. J Sci Food Agric. 2017 Mar;97(5):1517-1523. doi: 10.1002/jsfa.7894. Epub 2016 Aug 2. J Sci Food Agric. 2017. PMID: 27404217
The limit of detection was 0.11 g L(-1) (S/N = 3) and the pre-concentration factor was 200. The intra- and inter-day precision was 5.9 and 2.2% respectively. ...
The limit of detection was 0.11 g L(-1) (S/N = 3) and the pre-concentration factor was 200. The intra- and inter-day precision was 5 …
SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial.
Barkhordar M, Mohammadi M, Hadjibabaie M, Ghavamzadeh A. Barkhordar M, et al. Int J Hematol Oncol Stem Cell Res. 2018 Apr 1;12(2):77-83. Int J Hematol Oncol Stem Cell Res. 2018. PMID: 30233767 Free PMC article.
Patients were allocated to receive azithromycin 500 mg daily (n=48) or placebo (n=48) from day -6 to +12. All patients received high-dose chemotherapy, standard immunosuppressive regimen and supportive care according to institutional protocols. ...
Patients were allocated to receive azithromycin 500 mg daily (n=48) or placebo (n=48) from day -6 to +12. All patients receive …
Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation.
Barkhordar M, Kasaeian A, Tavakoli S, Vaezi M, Kamranzadeh Foumani H, Bahri T, Babakhani D, Mirzakhani L, Mousavi A, Mousavi SA, Ghavamzadeh A. Barkhordar M, et al. Int J Hematol Oncol Stem Cell Res. 2021 Jan 1;15(1):51-60. doi: 10.18502/ijhoscr.v15i1.5249. Int J Hematol Oncol Stem Cell Res. 2021. PMID: 33613900 Free PMC article.
We evaluated the clinical outcomes of 248 patients with acute leukemia and without matched sibling donors (MSD) who underwent alternative transplantation, including haploidentical (n=118), 10/10 matched unrelated (MUD, n=91), 9/10 mismatched unrelated (MMUD, n …
We evaluated the clinical outcomes of 248 patients with acute leukemia and without matched sibling donors (MSD) who underwent alternative tr …